A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

NCT05103657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG: BI 1358894
DRUG: Placebo

Sponsor

Boehringer Ingelheim